Boehringer Ingelheim launches a new poultry vaccine to combat Marek's disease, a significant challenge for Indian poultry farmers. The vaccine is designed to reduce disease outbreaks and promote flock health.
New Delhi, Nov 26 (PTI) Biopharmaceutical firm Boehringer Igelheim on Tuesday launched a next generation poultry vaccine to fight Marek's disease that remains a significant challenge in India.
Marek's disease is highly contagious primarily affecting chickens, caused by the Marek's disease virus (MDV), an alphaherpesvirus.
"Our vaccine is designed to aid farmers by reducing disease outbreaks, promoting flock health, and enhancing productivity," Boehringer Ingelheim India Country Head (Animal Health) Vinod Gopal said in a statement.
The company has conducted extensive trials of the vaccine across multiple regions. It not only provides effective, early, and long-lasting immunity but also plays a crucial role in supporting food security and safety, he added.
Home » Market News » Boehringer Launches Next-Gen Poultry Vaccine for Marek's Disease
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback